Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake

BACKGROUND: Laquinimod is an immunomodulatory drug under clinical investigation for the treatment of the progressive form of multiple sclerosis (MS) with both anti-inflammatory and neuroprotective effects. Excitotoxicity, a prominent pathophysiological feature of MS and of its animal model, experime...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Antonietta, Musella, Alessandra, De Vito, Francesca, Fresegna, Diego, Bullitta, Silvia, Rizzo, Francesca Romana, Centonze, Diego, Mandolesi, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756343/
https://www.ncbi.nlm.nih.gov/pubmed/29304807
http://dx.doi.org/10.1186/s12974-017-1048-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756343/
https://www.ncbi.nlm.nih.gov/pubmed/29304807
http://dx.doi.org/10.1186/s12974-017-1048-6

Ejemplares similares